These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33008927)

  • 1. Photoacoustic Molecular Imaging for the Identification of Lymph Node Metastasis in Head and Neck Cancer Using an Anti-EGFR Antibody-Dye Conjugate.
    Nishio N; van den Berg NS; Martin BA; van Keulen S; Fakurnejad S; Rosenthal EL; Wilson KE
    J Nucl Med; 2021 May; 62(5):648-655. PubMed ID: 33008927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic and sentinel lymph node mapping using intravenously delivered Panitumumab-IRDye800CW.
    Krishnan G; van den Berg NS; Nishio N; Juniper G; Pei J; Zhou Q; Lu G; Lee YJ; Ramos K; Iagaru AH; Baik FM; Colevas AD; Martin BA; Rosenthal EL
    Theranostics; 2021; 11(15):7188-7198. PubMed ID: 34158844
    [No Abstract]   [Full Text] [Related]  

  • 3. Optical molecular imaging can differentiate metastatic from benign lymph nodes in head and neck cancer.
    Nishio N; van den Berg NS; van Keulen S; Martin BA; Fakurnejad S; Teraphongphom N; Chirita SU; Oberhelman NJ; Lu G; Horton CE; Kaplan MJ; Divi V; Colevas AD; Rosenthal EL
    Nat Commun; 2019 Nov; 10(1):5044. PubMed ID: 31695030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Formalin Fixation for Near-Infrared Fluorescence Imaging with an Antibody-Dye Conjugate in Head and Neck Cancer Patients.
    Kapoor S; Lu G; van den Berg NS; Krishnan G; Pei J; Zhou Q; Martin BA; Baik FM; Rosenthal EL; Nishio N
    Mol Imaging Biol; 2021 Apr; 23(2):270-276. PubMed ID: 33078373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimal Dosing Strategy for Fluorescence-Guided Surgery with Panitumumab-IRDye800CW in Head and Neck Cancer.
    Nishio N; van den Berg NS; van Keulen S; Martin BA; Fakurnejad S; Zhou Q; Lu G; Chirita SU; Kaplan MJ; Divi V; Colevas AD; Rosenthal EL
    Mol Imaging Biol; 2020 Feb; 22(1):156-164. PubMed ID: 31054001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal Growth Factor Receptor-Targeted Fluorescence Molecular Imaging for Postoperative Lymph Node Assessment in Patients with Oral Cancer.
    Vonk J; de Wit JG; Voskuil FJ; Tang YH; Hooghiemstra WTR; Linssen MD; van den Broek E; Doff JJ; de Visscher SAHJ; Schepman KP; van der Vegt B; van Dam GM; Witjes MJH
    J Nucl Med; 2022 May; 63(5):672-678. PubMed ID: 34531264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of panitumumab-IRDye800 to image microscopic head and neck cancer in an orthotopic surgical model.
    Heath CH; Deep NL; Sweeny L; Zinn KR; Rosenthal EL
    Ann Surg Oncol; 2012 Nov; 19(12):3879-87. PubMed ID: 22669455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical comparison of near-infrared-labeled cetuximab and panitumumab for optical imaging of head and neck squamous cell carcinoma.
    Day KE; Sweeny L; Kulbersh B; Zinn KR; Rosenthal EL
    Mol Imaging Biol; 2013 Dec; 15(6):722-9. PubMed ID: 23715932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node metastasis in head and neck squamous carcinoma: Efficacy of intravoxel incoherent motion magnetic resonance imaging for the differential diagnosis.
    Liang L; Luo X; Lian Z; Chen W; Zhang B; Dong Y; Liang C; Zhang S
    Eur J Radiol; 2017 May; 90():159-165. PubMed ID: 28583628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of affibody, panitumumab, and EGF for near-infrared fluorescence imaging of EGFR- and EGFRvIII-expressing tumors.
    Gong H; Kovar JL; Cheung L; Rosenthal EL; Olive DM
    Cancer Biol Ther; 2014 Feb; 15(2):185-93. PubMed ID: 24100437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping of the perigastric lymphatic network using indocyanine green fluorescence imaging and tissue marking dye in clinically advanced gastric cancer.
    Park JH; Berlth F; Wang C; Wang S; Choi JH; Park SH; Suh YS; Kong SH; Park DJ; Lee HJ; Kwak Y; Kim WH; Yang HK
    Eur J Surg Oncol; 2022 Feb; 48(2):411-417. PubMed ID: 34625304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoprotein Nonmetastatic Melanoma Protein B as Potential Imaging Marker in Posttherapeutic Metastatic Head and Neck Cancer.
    van Schaik JE; Hanemaaijer SH; Halmos GB; Witjes MJH; van der Laan BFAM; van der Vegt B; Plaat BEC
    Otolaryngol Head Neck Surg; 2020 Dec; 163(6):1202-1208. PubMed ID: 32600105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of 3-Tesla diffusion-weighted magnetic resonance imaging for distinction of reactive and metastatic lymph nodes in head-and-neck carcinoma.
    Vijayalakshmi K; Raghuram PH; Saravanan K; Krithika CL; Kannan A
    J Cancer Res Ther; 2020; 16(3):587-593. PubMed ID: 32719272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping Sentinel Lymph Node Metastasis by Dual-probe Optical Imaging.
    Yang X; Wang Z; Zhang F; Zhu G; Song J; Teng GJ; Niu G; Chen X
    Theranostics; 2017; 7(1):153-163. PubMed ID: 28042324
    [No Abstract]   [Full Text] [Related]  

  • 15. Factors for Differential Outcome Across Cancers in Clinical Molecule-Targeted Fluorescence Imaging.
    Zhou Q; van den Berg NS; Kang W; Pei J; Nishio N; van Keulen S; Engelen MA; Lee YJ; Hom M; Vega Leonel JCM; Hart Z; Vogel H; Cayrol R; Martin BA; Roesner M; Shields G; Lui N; Gephart MH; Raymundo RC; Yi G; Granucci M; Grant GA; Li G; Rosenthal EL
    J Nucl Med; 2022 Nov; 63(11):1693-1700. PubMed ID: 35332092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Value of Diffusion Weighted Magnetic Resonance Imaging in Evaluation of Metastatic Neck Lymph Nodes in Head and Neck Cancer: A Sample of Iranian Patient.
    Alamolhoda F; Faeghi F; Bakhshandeh M; Ahmadi A; Sanei Taheri M; Aabbasi S
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1789-1795. PubMed ID: 31244301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-parametric arterial spin labeling and diffusion-weighted imaging in differentiation of metastatic from reactive lymph nodes in head and neck squamous cell carcinoma.
    Razek AAKA; Helmy E
    Eur Arch Otorhinolaryngol; 2021 Jul; 278(7):2529-2535. PubMed ID: 33000301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluorescence molecular imaging for identification of high-grade dysplasia in patients with head and neck cancer.
    Fakurnejad S; van Keulen S; Nishio N; Engelen M; van den Berg NS; Lu G; Birkeland A; Baik F; Colevas AD; Rosenthal EL; Martin BA
    Oral Oncol; 2019 Oct; 97():50-55. PubMed ID: 31421471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Lymph Node Metastases by Ultra-pH-Sensitive Polymeric Nanoparticles.
    Bennett ZT; Feng Q; Bishop JA; Huang G; Sumer BD; Gao J
    Theranostics; 2020; 10(7):3340-3350. PubMed ID: 32194872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraoperative fluorescence delineation of head and neck cancer with a fluorescent anti-epidermal growth factor receptor nanobody.
    van Driel PB; van der Vorst JR; Verbeek FP; Oliveira S; Snoeks TJ; Keereweer S; Chan B; Boonstra MC; Frangioni JV; van Bergen en Henegouwen PM; Vahrmeijer AL; Lowik CW
    Int J Cancer; 2014 Jun; 134(11):2663-73. PubMed ID: 24222574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.